Construction and evaluation of a multistage combination vaccine against malaria
Authors:
- Xiangyang XueXXXiangyang Xue
- Li QuLQLi Qu
- Weiqing PanWPWeiqing Pan
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trialThe Lancet, 2005
- Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trialThe Lancet, 2004
- Fusion of Two Malaria Vaccine Candidate Antigens Enhances Product Yield, Immunogenicity, and Antibody-Mediated Inhibition of Parasite Growth In VitroThe Journal of Immunology, 2004
- Malaria Vaccine: Candidate Antigens, Mechanisms, Constraints and ProspectsScandinavian Journal of Immunology, 2002
- Structure of Domain III of the Blood-stage Malaria Vaccine Candidate, Plasmodium falciparum Apical Membrane Antigen 1 (AMA1)Journal of Molecular Biology, 2002
- Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trialThe Lancet, 2001
- Antibodies against Merozoite Surface Protein (Msp)-119 Are a Major Component of the Invasion-Inhibitory Response in Individuals Immune to MalariaJournal of Experimental Medicine, 2001
- Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC)Vaccine, 1998
- PATHWAYS AND STRATEGIES FOR DEVELOPING A MALARIA BLOOD-STAGE VACCINEAnnual Review of Immunology, 1998
- T Cell Responses to Pre-Erythrocytic Stages of Malaria: Role in Protection and Vaccine Development Against Pre-Erythrocytic StagesAnnual Review of Immunology, 1993